Undifferentiated early gastric cancer
Conditions
Interventions
Control Group:Undergo ESD procedure + oral placebo
Experimental Group:Undergo ESD procedure and take oral administration of Biling Weitong granules.
Sponsors
Xinxiang Central Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1. Meets the diagnostic criteria for undifferentiated early gastric cancer as specified in the "Gastric Cancer Diagnosis and Treatment Guidelines (2018 Edition)." 2. Meets the diagnostic criteria for the Qi stagnation and blood stasis syndrome as specified in the "Chinese Medical Diagnosis and Treatment Guidelines for Malignant Tumors" (main symptoms: stabbing pain in the gastric region, discomfort below the heart; secondary symptoms: nausea, vomiting of blood, black stools, dark complexion, tongue with ecchymosis, and a deep, fine, and thready pulse). 3. Age between 18-75 years, gender. 4. Able to tolerate ESD surgery and agrees to receive treatment with Bilinguotong granules. 5. Voluntarily participates in this study and signs the informed consent form.
Exclusion criteria
Exclusion criteria: 1. Subjects with immune dysfunction or hemostatic disorders. 2. Subjects with other primary malignant tumors. 3. Subjects with severe mental or psychological disorders who are unable to comply with treatment and follow-up. 4. Subjects with allergic constitution or known allergy to components of the investigational drug. 5. Subjects who have received other anti-tumor treatments prior to enrollment or are currently participating in other clinical studies.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Overall clinical efficacy rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| Postoperative complications;Gastrointestinal Function Recovery Indices;Pain score;Traditional Chinese Medicine Syndromes Total Score;Tumor Markers;Inflammatory Factors; | — |
Countries
China
Contacts
Public ContactChen Yafei
Xinxiang Central Hospital
Outcome results
None listed